Psilocybin, the active psychedelic ingredient in magic mushrooms, has been proven to impact patients with depression positively. Vail Health’s OPTIMIZE study, which will administer doses of psilocybin ...

A study, published in Molecular Psychiatry, led by Prof. Bernard Lerer from the Department of Psychiatry at the Hadassah—Hebrew University Medical Center shows promising results for using psilocybin, ...

A new investigation published in the journal Neuropharmacology offers a nuanced perspective on the popular practice of ...

Participants received a single dose of either 25 mg of COMP360 or placebo On track for disclosure of top-line 6-week primary endpoint results in late June “Completing dosing of all participants in ...

Psilocybin therapy reduced depression symptoms in clinicians who developed these symptoms after frontline clinical work during the COVID-19 pandemic, a small randomized trial showed. At day 28, the ...

Psilocybin, the active compound in hallucinogenic mushrooms, is edging into mainstream psychiatry in parts of Europe – with Switzerland already treating patients and the Czech Republic opening tightly ...

A popular modern trend involves taking tiny amounts of psychedelic mushrooms to boost brain power, but new evidence suggests the benefits may be largely imaginary. A rigorous scientific investigation ...

AURORA, Colo — Researchers at UCHealth are conducting a clinical trial to determine whether psilocybin can ease anxiety and depression in advanced cancer patients. The National Cancer Institute-funded ...

SAN FRANCISCO (KPIX) — On a quiet plot of land in rural New Mexico, Jeff Deming feels like he’s really living, once again. “Mentally, it’s day and night,” he said. He’s able to do the things that make ...

Participants received a single dose of either 25 mg of COMP360 or placebo On track for disclosure of top-line 6-week primary endpoint results in late June To date, the COMP005 trial is the largest, ...